Although ZNS is well-known as a T-type calcium channel blocker, our experiments revealed that it also acts as a modulator to ameliorate the voltage dependence of CaV3.1 mutation, causing SCA42. This evidence concerns the gene CACNA1G and spinocerebellar ataxia type 42.